𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis C virus dynamics in vivo and the antiviral efficacy of interferon alfa therapy

✍ Scribed by Howard C. Thomas; M. E. Török; G. R. Foster

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
44 KB
Volume
29
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of interferon alfa on the dynamic
Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo
✍ S Zeuzem; J M Schmidt; J Lee; B Ruster; W K Roth 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 1 views

recently published data on human immunodeficiency vi-In about 30% to 40% of patients with chronic hepatitis rus type 1 (HIV-1) suggesting that both RNA viruses rep-C, treatment with recombinant interferon alfa (r-IFNa) licate continuously and highly productive in vivo. The causes a decrease of serum

Hepatitis C virus dynamics in vivo: Effe
Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover
✍ Prof. med. Stefan Zeuzem; Jürgen M. Schmidt; Jung-hun Lee; Michael von Wagner; G 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

Treatment of patients with chronic hepatitis C with recombinant interferon alfa (rIFN-alpha) can cause a decrease of serum transaminases and hepatitis C virus (HCV) RNA. Recent trials evaluating combination therapy of IFN-alpha and ribavirin suggested a potential synergistic effect. From serial meas

Intrahepatic hepatitis C virus–specific
Intrahepatic hepatitis C virus–specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C
✍ David R. Nelson; Constantine G. Marousis; Tomoyoshi Ohno; Gary L. Davis; Johnson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes (CTL) have been shown to play a role in host defense and pathogenesis of chronic HCV infection. Our aim was to test the hypothesis that intrahepatic HCV-specific CTL activity may impact subsequent response to interferon alfa (IFN-␣) therapy. O

The efficacy of prophylactic interferon
The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation
✍ Patricia A. Sheiner; Peter Boros; Franklin M. Klion; Swan N. Thung; Leona Kim Sc 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

Clinical recurrence of hepatitis C after liver transplantation can lead to cirrhosis, liver failure, and death. In patients undergoing liver transplantation for hepatitis C, we assessed the efficacy of interferon alfa-2b (IFN) in preventing recurrent hepatitis. We randomized 86 patients to either an